athenahealth, Inc. Reports Second Quarter Fiscal Year 2016 Results

Go back to athenahealth, Inc. Reports Second Quarter Fiscal Year 2016 Results

FBR Capital Cuts Price Target on Athenahealth (ATHN) Following 2Q Miss

July 22, 2016 7:13 AM EDT

FBR Capital reiterated a Market Perform rating on Athenahealth (NASDAQ: ATHN), and cut the price target to $140.00 (from $145.00), following the company's 2Q earnings report. Revenue was $262 million, below the consensus of $274 million. Non-GAAP adjusted EPS was $0.34, compared with the consensus of $0.42.

Analyst Steven Halper... More

Deutsche Bank Downgrades athenahealth (ATHN) to Hold

July 22, 2016 6:58 AM EDT

Deutsche Bank downgraded athenahealth (NASDAQ: ATHN) from Buy to Hold with a price target of $147.00 (from $165.00). Analyst George Hill pointed out disturbing underlying performance metrics.

"Athena reported concerning Q2 results after market close, where the revenue and earnings miss was among the... More

UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End

July 21, 2016 4:06 PM EDT

(Updated - July 25, 2016 10:31 AM EDT)

(Update corrects headline to say COO to step down, not CEO)

Athenahealth (NASDAQ: ATHN) reported Q2 EPS of $0.34, $0.08 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $261.9 million versus the consensus estimate of $274.07... More